Chris Benecchi

Chris Benecchi joined Sage in September 2021, bringing a track record of designing commercial strategies and launching novel therapies that sustained long-term growth in highly competitive markets. In his role as Chief Business Officer, Chris leads Sage’s global commercial efforts across all Sage programs, as well as corporate strategy, new product planning, program management, and alliances.

He most recently served as Vice President, Global Head of Commercial Excellence at Alexion, where he led integrated global launch planning and readiness. Previously, he spent eight years at UCB in commercial roles of increasing responsibility including Global Launch Head, Commercial and Medical Affairs, Immunology, and Global Commercial Strategy Lead, Immunology. He began his career in sales at Johnson & Johnson and held sales leadership and senior marketing roles at Takeda.

Chris received an MBA from Duke University and a B.A. from Colby College.